Tetraphase Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their therapeutic procedures and clinical research.
” ERV is being evaluated for the use in the therapeutic treatment of tularemia, plague and anthrax in animal models”
Tetraphase Pharmaceuticals, Inc. (Tetraphase), incorporated on July 7, 2006, is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Company is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous (IV) and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant Gram-negative infections. The Company also develops TP-6076 for multidrug-resistant Gram- negative infections. [Source: Reuters]
Company Website: https://www.tphase.com